A collaborative team of experts in drug screening, DNA repair, and cancer biology will carry out the project. All three investigators are currently funded by the National Institutes of Health for research in the biomolecular and biomedical area. Dr. Yuan Liu and Dr. Yuk-Ching Tse-Dinh are both in the Faculty Mentor Program and are members of the Department of Chemistry and Biochemistry in the College of Arts & Sciences; Dr. Irina Agoulnik is a faculty member in the Department of Cellular Biology and Pharmacology in the Herbert Wertheim College of Medicine.
Experts in cancer biology, DNA repair and drug screening, they will explore new leads for drug treatments of prostate cancer. This novel approach investigates the biomolecular mechanisms of the disease that has great new therapy potential. The findings will be used to develop new therapies that, once tested, will directly benefit approximately 3,500 Broward residents suffering from prostate cancer annually.